
How Is AI Changing Breast Cancer Education?
As LLMs expand access to cancer information, Prakash Peddi, MD, encourages patients to use available resources to better understand their disease and treatment options.
Artificial intelligence (AI) tools such as ChatGPT and Claude are giving patients new ways to access information about cancer and available treatments. As these resources become more widely used, understanding one's diagnosis and discussing treatment options with an oncologist remain important aspects of informed decision-making in hormone receptor (HR)–positive/HER2-negative metastatic breast cancer.
In a video interview with Targeted OncTM, Prakash Peddi, MD, of Willis Knighton Health, discusses the growing availability of AI-powered information and encouraged patients to become more involved in understanding their disease, exploring clinical trials, and evaluating available treatment options with their physicians.
Peddi emphasizes that patients have access to more information than ever before, but becoming familiar with their specific diagnosis remains essential. He encourages patients to invest time in understanding their disease and learning about potential treatment approaches. Greater disease awareness can help patients ask more informed questions and have more meaningful discussions with their oncologists.
He also encourages patients to investigate clinical trials available in their area, noting the importance of understanding the opportunities that may exist beyond standard treatment options.
Another important consideration is addressing misconceptions surrounding chemotherapy. Peddi explains that some patients may hesitate to pursue treatment because they anticipate significant adverse effects. However, the treatment landscape for metastatic HR-positive breast cancer has evolved, and chemotherapy is not necessarily the first approach clinicians pursue.
With additional therapeutic options available, physicians can consider different treatment strategies and potentially delay chemotherapy. Peddi also notes that chemotherapy drugs have become more sophisticated than those used in the past.
Ultimately, Peddi encourages patients to take advantage of the information and resources available to them while maintaining open communication with their care teams. He recommended discussing all available treatment options, understanding potential adverse effects, and asking difficult questions before making decisions.
As AI tools continue to expand access to cancer-related information, patient education and meaningful physician discussions remain essential to helping individuals understand their options and make informed treatment decisions.
Related to this article








